Doctor Receives 30 Months in Matthew Perry Ketamine Case
Dr. Salvador Plasencia became the first person sentenced in connection with actor Matthew Perry's 2023 ketamine overdose death.
Read More
Survey: 1.6 Million Americans Received Ketamine Treatment Last Year
A major new survey found that 1.6 million American adults received ketamine treatment in a supervised medical facility last year.
Read More
Exploding Head Syndrome: Ketamine Shows Promise for Rare Sleep Disorder
A man suffering from exploding head syndrome for over five years found relief through an unexpected treatment: sublingual ketamine.
Read More
Chinese Scientists Unlock the Mystery Behind Ketamine’s Rapid Relief for Depression
Chinese researchers have discovered a breakthrough that could transform the way ketamine can treat depression.
Read More
Cleveland Clinic Study Validates Low Dose Ketamine for Chronic Pain
Cleveland Clinic has published the largest study to date examining low dose ketamine infusions for chronic refractory pain.
Read More
FDA Program Promises to End Years of Ketamine Shortages for Mental Health Clinics
Phlow Corp. has been selected for the FDA's inaugural Commissioner's National Priority Voucher Pilot Program to manufacture ketamine's active pharmaceutical ingredient domestically.
Read More
October 2025 Roundup: What Ketamine Treatment Costs Across the United States
The cost of ketamine therapy continues to evolve. Here's what ketamine treatments cost across the US in October of 2025.
Read More
Introducing the Ketamine Industry’s Most Comprehensive Professional Liability Coverage
Most ketamine clinics think their liability insurance their ketamine treatments -- but for most it doesn't. We solved this problem.
Read More
September 2025 Roundup: What Ketamine Treatment Costs Across the United States
This September 2025 roundup examines the latest ketamine therapy pricing data from social media platforms, forums, and clinic websites.
Read More
IV Ketamine Shows Superior Results Over Nasal Esketamine for Treatment Resistant Depression
A new study shows that IV ketamine delivers more effective relief with treatment resistant depression compared to its nasal counterpart
Read More